Cargando…

CCR7 and its related molecules may be potential biomarkers of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a chronic progressive cardiovascular disease characterized by vascular remodeling and leading to right‐heart failure. The purpose of this research was to further study the pathogenesis of PAH and to detect potential prognostic signatures. Differentially expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Mengsi, Li, Xiuchun, Dong, Haoru, Wang, Ying, Huang, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167855/ https://www.ncbi.nlm.nih.gov/pubmed/33630421 http://dx.doi.org/10.1002/2211-5463.13130

Ejemplares similares

Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension
por: Dong, Haoru, et al.
Publicado: (2021)

FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ
por: Wang, Meibin, et al.
Publicado: (2022)

FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19
por: Li, Xiuchun, et al.
Publicado: (2022)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Novel biomarkers for pulmonary arterial hypertension
por: Anwar, Anjum, et al.
Publicado: (2016)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertension
por: Minai, Omar A.
Publicado: (2014)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

COVID-19 patients may become predisposed to pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2021)

Novel biomarkers for risk stratification in pulmonary arterial hypertension
por: Zelniker, Thomas, et al.
Publicado: (2015)

Evidence for a Role of CCR6+ T Cells in Chronic Thromboembolic Pulmonary Hypertension
por: van Uden, Denise, et al.
Publicado: (2022)

Regulation of CCR7-dependent cell migration through CCR7 homodimer formation
por: Kobayashi, Daichi, et al.
Publicado: (2017)

Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
por: Lim, Herman D., et al.
Publicado: (2021)

Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1–7)-Mas Axis in Pulmonary Arterial Hypertension
por: Zhang, Feng, et al.
Publicado: (2021)

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
por: Casserly, Brian, et al.
Publicado: (2009)

MicroRNA-17 as a potential diagnostic biomarker in pulmonary arterial hypertension
por: Li, Haiwen, et al.
Publicado: (2020)

Potential mechanisms and serum biomarkers involved in sex differences in pulmonary arterial hypertension
por: Li, Chan, et al.
Publicado: (2020)

The outcome of pulmonary hypertension and its association with pulmonary artery dilatation
por: Duijnhouwer, A. L., et al.
Publicado: (2020)

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2019)

Pulmonary arterial banding in mice may be a suitable model for studies on ventricular mechanics in pediatric pulmonary arterial hypertension
por: Dufva, Melanie J., et al.
Publicado: (2021)

Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)

Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate
por: Colvin, Kelley L., et al.
Publicado: (2014)

Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
por: Sun, Qian, et al.
Publicado: (2020)

Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
por: Katz, Stuart D.
Publicado: (2007)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020)

Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension
por: Hiraishi, Keizo, et al.
Publicado: (2022)

Effects of baicalin on collagen Ι and collagen ΙΙΙ expression in pulmonary arteries of rats with hypoxic pulmonary hypertension
por: LIU, PANPAN, et al.
Publicado: (2015)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
por: Li, Qian, et al.
Publicado: (2023)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

May We Use Non-Invasive Indices of Aortic Stiffness and Endothelial Glycocalyx as Biomarkers for Idiopathic Pulmonary Artery Hypertension Follow-Up?
por: Triantafyllidi, Helen, et al.
Publicado: (2021)

CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2021)

Distinct Fates of Chemokine and Surrogate Molecule Gradients: Consequences for CCR7-Guided Dendritic Cell Migration
por: Artinger, Marc, et al.
Publicado: (2022)

The Ins and Outs of CCR7 in the Thymus
por: Witt, Colleen M., et al.
Publicado: (2004)

Circulating microparticles in severe pulmonary arterial hypertension increase intercellular adhesion molecule-1 expression selectively in pulmonary artery endothelium
por: Blair, Leslie A., et al.
Publicado: (2016)

Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2018)

Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
por: Hemnes, Anna, et al.
Publicado: (2020)

Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Moccaldi, Beatrice, et al.
Publicado: (2023)

Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension
por: Wang, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p6lbk85d5ppckg2g0tqqhlf6db